• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜静脉闭塞之谜:静脉的血管活性和内皮素-1 的可能参与。

Mystery of Retinal Vein Occlusion: Vasoactivity of the Vein and Possible Involvement of Endothelin-1.

机构信息

Department of Ophthalmology, Osaka Medical College, Takatsuki, Japan.

出版信息

Biomed Res Int. 2017;2017:4816527. doi: 10.1155/2017/4816527. Epub 2017 Aug 20.

DOI:10.1155/2017/4816527
PMID:28904960
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5585553/
Abstract

Retinal vein occlusion (RVO) is a common vascular disease of retina; however, the pathomechanism leading to RVO is not yet clear. In general, increasing age, hypertension, arteriosclerosis, diabetes mellitus, dyslipidemia, cardiovascular disorder, and cerebral stroke are systemic risk factors of RVO. However, RVO often occur in the unilateral eye and sometimes develop in young subjects who have no arteriosclerosis. In addition, RVO show different variations on the degrees of severity; some RVO are resolved without any treatment and others develop vision-threatening complications such as macular edema, combined retinal artery occlusion, vitreous hemorrhage, and glaucoma. Clinical conditions leading to RVO are still open to question. In this review, we discuss how to treat RVO in practice by presenting some RVO cases. We also deliver possible pathomechanisms of RVO through our clinical experience and animal experiments.

摘要

视网膜静脉阻塞(RVO)是一种常见的视网膜血管疾病;然而,导致 RVO 的发病机制尚不清楚。一般来说,年龄增长、高血压、动脉硬化、糖尿病、血脂异常、心血管疾病和脑卒中等是 RVO 的全身性危险因素。然而,RVO 常发生于单侧眼,有时也发生于无动脉硬化的年轻患者。此外,RVO 在严重程度上表现出不同的变化;一些 RVO 未经任何治疗即可自行消退,而另一些则会出现威胁视力的并发症,如黄斑水肿、合并视网膜动脉阻塞、玻璃体积血和青光眼。导致 RVO 的临床情况仍存在疑问。在这篇综述中,我们通过介绍一些 RVO 病例,讨论了如何在实践中治疗 RVO。我们还通过临床经验和动物实验,阐述了 RVO 的可能发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/fb1b51319ec2/BMRI2017-4816527.015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/423c7d3a95c1/BMRI2017-4816527.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/141af06752fe/BMRI2017-4816527.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/41b4167cf354/BMRI2017-4816527.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/6fffe771bdd1/BMRI2017-4816527.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/2f3ab0d8e52c/BMRI2017-4816527.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/11dfc3273681/BMRI2017-4816527.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/a33e53570b0b/BMRI2017-4816527.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/4212ecc459f8/BMRI2017-4816527.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/4f4d24b8b868/BMRI2017-4816527.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/1ec901a43238/BMRI2017-4816527.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/a460f3d6f2be/BMRI2017-4816527.011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/fac4cdcc7751/BMRI2017-4816527.012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/731c63b74e3b/BMRI2017-4816527.013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/4bc67d4589c2/BMRI2017-4816527.014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/fb1b51319ec2/BMRI2017-4816527.015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/423c7d3a95c1/BMRI2017-4816527.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/141af06752fe/BMRI2017-4816527.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/41b4167cf354/BMRI2017-4816527.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/6fffe771bdd1/BMRI2017-4816527.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/2f3ab0d8e52c/BMRI2017-4816527.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/11dfc3273681/BMRI2017-4816527.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/a33e53570b0b/BMRI2017-4816527.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/4212ecc459f8/BMRI2017-4816527.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/4f4d24b8b868/BMRI2017-4816527.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/1ec901a43238/BMRI2017-4816527.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/a460f3d6f2be/BMRI2017-4816527.011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/fac4cdcc7751/BMRI2017-4816527.012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/731c63b74e3b/BMRI2017-4816527.013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/4bc67d4589c2/BMRI2017-4816527.014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a5/5585553/fb1b51319ec2/BMRI2017-4816527.015.jpg

相似文献

1
Mystery of Retinal Vein Occlusion: Vasoactivity of the Vein and Possible Involvement of Endothelin-1.视网膜静脉闭塞之谜:静脉的血管活性和内皮素-1 的可能参与。
Biomed Res Int. 2017;2017:4816527. doi: 10.1155/2017/4816527. Epub 2017 Aug 20.
2
[Risk factors and visual prognosis of 407 patients with retinal vein occlusion].407例视网膜静脉阻塞患者的危险因素及视力预后
Zhonghua Yan Ke Za Zhi. 1991 Sep;27(5):271-4.
3
Impact of cardiovascular risk factors on incidence and severity of Retinal Vein Occlusion.心血管危险因素对视网膜静脉闭塞发病和严重程度的影响。
Clin Ter. 2020 Nov-Dec;171(6):e534-e538. doi: 10.7417/CT.2020.2269.
4
Retinal vein occlusion: genetic predisposition and systemic risk factors.视网膜静脉阻塞:遗传易感性和全身危险因素。
Blood Coagul Fibrinolysis. 2013 Apr;24(3):279-83. doi: 10.1097/MBC.0b013e32835bfda1.
5
Ischemic retinal vein occlusion: characterizing the more severe spectrum of retinal vein occlusion.缺血性视网膜静脉阻塞:视网膜静脉阻塞更严重谱的特征。
Surv Ophthalmol. 2018 Nov-Dec;63(6):816-850. doi: 10.1016/j.survophthal.2018.04.005. Epub 2018 Apr 27.
6
Vasoactivity of retinal veins: A potential involvement of endothelin-1 (ET-1) in the pathogenesis of retinal vein occlusion (RVO).视网膜静脉的血管活性:内皮素-1(ET-1)在视网膜静脉阻塞(RVO)发病机制中的潜在作用。
Exp Eye Res. 2018 Nov;176:207-209. doi: 10.1016/j.exer.2018.07.016. Epub 2018 Jul 17.
7
Retinal vein occlusion: an approach to diagnosis, systemic risk factors and management.视网膜静脉阻塞:诊断方法、全身危险因素及治疗
Intern Med J. 2008 Dec;38(12):904-10. doi: 10.1111/j.1445-5994.2008.01720.x.
8
Spectrum of Eye Disease in Diabetes (SPEED) in India: A prospective facility-based study. Report # 3. Retinal vascular occlusion in patients with type 2 diabetes mellitus.印度的糖尿病眼病谱研究(SPEED):一项基于医疗机构的前瞻性研究。报告#3. 2 型糖尿病患者视网膜血管闭塞。
Indian J Ophthalmol. 2020 Feb;68(Suppl 1):S27-S31. doi: 10.4103/ijo.IJO_1934_19.
9
ENDOTHELIN-1 AS A RISK FACTOR IN RETINAL VEIN OCCLUSION.内皮素-1 作为视网膜静脉阻塞的一个危险因素。
Retina. 2022 Apr 1;42(4):738-743. doi: 10.1097/IAE.0000000000003374.
10
Incidence and risk factors for retinal vein occlusion at the University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria.尼日利亚哈科特港哈科特港大学教学医院视网膜静脉阻塞的发病率及危险因素
Niger J Clin Pract. 2014 Jul-Aug;17(4):462-6. doi: 10.4103/1119-3077.134040.

引用本文的文献

1
The Diagnosis and Treatment of Branch Retinal Vein Occlusions: An Update.视网膜分支静脉阻塞的诊断与治疗:最新进展
Biomedicines. 2025 Jan 5;13(1):105. doi: 10.3390/biomedicines13010105.
2
Multimodal deep transfer learning to predict retinal vein occlusion macular edema recurrence after anti-VEGF therapy.多模态深度迁移学习预测抗VEGF治疗后视网膜静脉阻塞性黄斑水肿的复发
Heliyon. 2024 Apr 10;10(8):e29334. doi: 10.1016/j.heliyon.2024.e29334. eCollection 2024 Apr 30.
3
Ocular Effects of MEK Inhibitor Therapy: Literature Review, Clinical Presentation, and Best Practices for Mitigation.

本文引用的文献

1
Clinical Features of Japanese Patients with Central Retinal Vein Occlusion Complicated by Normal-Tension Glaucoma: A Retrospective Study.中心性视网膜静脉阻塞合并正常眼压性青光眼的日本患者的临床特征:一项回顾性研究。
Ophthalmologica. 2017;237(3):173-179. doi: 10.1159/000459636. Epub 2017 Mar 11.
2
CHOROIDAL BLOOD FLOW AND THICKNESS AS PREDICTORS FOR RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION.脉络膜血流和厚度可预测抗血管内皮生长因子治疗对分支型视网膜静脉阻塞继发黄斑水肿的疗效。
Retina. 2018 Mar;38(3):550-558. doi: 10.1097/IAE.0000000000001566.
3
MEK抑制剂治疗的眼部效应:文献综述、临床表现及缓解的最佳实践
Oncologist. 2024 May 3;29(5):e616-e621. doi: 10.1093/oncolo/oyae014.
4
Macular dynamics and visual acuity prognosis in retinal vein occlusions - ways to connect.视网膜静脉阻塞的黄斑动力学和视力预后——连接的途径。
Rom J Ophthalmol. 2023 Jul-Sep;67(3):312-324. doi: 10.22336/rjo.2023.51.
5
Evaluating the utility of deep learning for predicting therapeutic response in diabetic eye disease.评估深度学习在预测糖尿病眼病治疗反应方面的效用。
Front Ophthalmol (Lausanne). 2022;2. doi: 10.3389/fopht.2022.852107. Epub 2022 Aug 12.
6
Similarities and differences in systemic risk factors for retinal artery occlusion and retinal vein occlusion: A nationwide case-control study.视网膜动脉阻塞和视网膜静脉阻塞全身危险因素的异同:一项全国性病例对照研究。
Int Ophthalmol. 2023 Mar;43(3):817-824. doi: 10.1007/s10792-022-02483-3. Epub 2022 Sep 2.
7
Intravitreal Administration Effect of Adipose-Derived Mesenchymal Stromal Cells Combined with Anti-VEGF Nanocarriers, in a Pharmaceutically Induced Animal Model of Retinal Vein Occlusion.脂肪来源间充质基质细胞联合抗血管内皮生长因子纳米载体玻璃体内给药在药物诱导的视网膜静脉阻塞动物模型中的作用
Stem Cells Int. 2022 Feb 23;2022:2760147. doi: 10.1155/2022/2760147. eCollection 2022.
8
Altered brain network centrality in patients with retinal vein occlusion: a resting-state fMRI study.视网膜静脉阻塞患者脑网络中心性的改变:一项静息态功能磁共振成像研究。
Int J Ophthalmol. 2021 Nov 18;14(11):1741-1747. doi: 10.18240/ijo.2021.11.14. eCollection 2021.
9
Effects of Antithrombotic Agents on Ophthalmological Outcomes, Cardiovascular Risk, and Mortality in Hypertensive Patients with Retinal Vein Occlusion: An Exploratory Retrospective Study.抗血栓药物对伴有视网膜静脉阻塞的高血压患者眼科结局、心血管风险和死亡率的影响:一项探索性回顾性研究。
Medicina (Kaunas). 2021 Sep 25;57(10):1017. doi: 10.3390/medicina57101017.
10
Endosomal disentanglement of a transducible artificial transcription factor targeting endothelin receptor A.靶向内皮素受体 A 的可转导人工转录因子的内体松解。
Mol Ther. 2022 Feb 2;30(2):855-867. doi: 10.1016/j.ymthe.2021.09.018. Epub 2021 Sep 20.
RETINAL BLOOD FLOW AFTER INTRAVITREAL BEVACIZUMAB IS A PREDICTIVE FACTOR FOR OUTCOMES OF MACULAR EDEMA ASSOCIATED WITH CENTRAL RETINAL VEIN OCCLUSION.
玻璃体内注射贝伐单抗后视网膜血流是与中央性视网膜静脉阻塞相关的黄斑水肿结局的预测因素。
Retina. 2018 Feb;38(2):283-291. doi: 10.1097/IAE.0000000000001531.
4
Suppressed endothelin-1 by anti-VEGF therapy is important for patients with BRVO-related macular edema to improve their vision.抗VEGF治疗抑制内皮素-1对视网膜分支静脉阻塞相关黄斑水肿患者改善视力很重要。
EPMA J. 2016 Aug 24;7(1):18. doi: 10.1186/s13167-016-0066-2. eCollection 2016.
5
Retinal venous pulsation: Expanding our understanding and use of this enigmatic phenomenon.视网膜静脉搏动:拓展我们对这一神秘现象的理解和应用。
Prog Retin Eye Res. 2016 Nov;55:82-107. doi: 10.1016/j.preteyeres.2016.06.003. Epub 2016 Jul 11.
6
Systematic literature review of treatments for management of complications of ischemic central retinal vein occlusion.缺血性视网膜中央静脉阻塞并发症治疗的系统文献综述
BMC Ophthalmol. 2016 Jul 11;16:104. doi: 10.1186/s12886-016-0282-5.
7
Changes of retinal flow volume after intravitreal injection of bevacizumab in branch retinal vein occlusion with macular edema: a case series.玻璃体腔内注射贝伐单抗治疗黄斑水肿型视网膜分支静脉阻塞后视网膜血流量的变化:病例系列研究
BMC Ophthalmol. 2016 May 25;16:61. doi: 10.1186/s12886-016-0239-8.
8
Correlation between optic nerve head circulation and visual function before and after anti-VEGF therapy for central retinal vein occlusion: prospective, interventional case series.抗血管内皮生长因子(VEGF)治疗中心性视网膜静脉阻塞前后视神经乳头循环与视觉功能的相关性:前瞻性干预性病例系列研究
BMC Ophthalmol. 2016 Apr 5;16:36. doi: 10.1186/s12886-016-0211-7.
9
Local Modulation of Retinal Vein Tone.视网膜静脉张力的局部调节
Invest Ophthalmol Vis Sci. 2016 Feb;57(2):412-9. doi: 10.1167/iovs.15-18358.
10
Cotton Wool Spots after Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Associated with Central Retinal Vein Occlusion.抗血管内皮生长因子治疗视网膜中央静脉阻塞相关黄斑水肿后的棉絮斑
Ophthalmologica. 2016;235(2):106-13. doi: 10.1159/000443622. Epub 2016 Jan 23.